Letter to the Editor
ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
Jean Carlos Lipreri da Silvaa, Juan Luiz Coelho-Silvab, Hugo Passos Vicaria, Keli Limac, Eduardo Magalhães Regoc, Fabiola Trainab, João Agostinho Machado-Netoa,
Corresponding author
jamachadoneto@usp.br
Corresponding author at: Department of Pharmacology, Institute of Biomedical Sciences of University of São Paulo, Av. Prof. Lineu Prestes, 1524, CEP 05508-900, São Paulo, SP, Brazil.
Corresponding author at: Department of Pharmacology, Institute of Biomedical Sciences of University of São Paulo, Av. Prof. Lineu Prestes, 1524, CEP 05508-900, São Paulo, SP, Brazil.
a Institute of Biomedical Sciences, University de São Paulo (USP), São Paulo, SP, Brazil
b Hematology and Clinical Oncology, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (FMUSP), Ribeirão Preto, SP, Brazil
c Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology Hospital das Clínicas, Faculdade de Medicina, Universidade de Sao Paulo, (LIM-31 - HCFMUSP) Sao Paulo, SP, Brazil
Read
2551
Timeswas read the article
797
Total PDF
1754
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 61 | 32 | 93 |
| 2025 11 | 129 | 50 | 179 |
| 2025 10 | 80 | 28 | 108 |
| 2025 9 | 65 | 24 | 89 |
| 2025 8 | 63 | 10 | 73 |
| 2025 7 | 61 | 18 | 79 |
| 2025 6 | 60 | 20 | 80 |
| 2025 5 | 70 | 15 | 85 |
| 2025 4 | 53 | 13 | 66 |
| 2025 3 | 67 | 16 | 83 |
| 2025 2 | 49 | 24 | 73 |
| 2025 1 | 49 | 24 | 73 |
| 2024 12 | 34 | 17 | 51 |
| 2024 11 | 50 | 24 | 74 |
| 2024 10 | 44 | 29 | 73 |
| 2024 9 | 73 | 39 | 112 |
| 2024 8 | 51 | 46 | 97 |
| 2024 7 | 53 | 30 | 83 |
| 2024 6 | 50 | 20 | 70 |
| 2024 5 | 239 | 74 | 313 |
| 2024 4 | 111 | 31 | 142 |
| 2024 3 | 80 | 32 | 112 |
| 2024 2 | 26 | 20 | 46 |
| 2024 1 | 22 | 15 | 37 |
| 2023 12 | 15 | 14 | 29 |
| 2023 11 | 30 | 33 | 63 |
| 2023 10 | 25 | 37 | 62 |
| 2023 9 | 22 | 26 | 48 |
| 2023 8 | 22 | 36 | 58 |
Show all
